Multi-platform integration of brain and CSF proteomes reveals biomarker panels for Alzheimer's disease
Alzheimer's disease (AD) is the leading cause of dementia and represents a progressive, irreversible neurodegenerative disorder. Given the complexity and heterogeneity of AD, which involves numerous interrelated molecular pathways, large-scale proteomics datasets are essential for …
Read PDF